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Our team (Jacek Białkowski, Małgorzata Szkutnik, Roland Fiszer) has recently received a scientific award from the Polish Cardiac Society for the year 2017. This considerable distinction was related to our 24 articles published between the years 2012 and 2017. These publications were associated with progress in the interventional treatment of congenital and structural heart defects.
The main topics included: 1. Dilatation of the native coarctation (CoA) and recoarctation (ReCoA) of the aorta with stents. We published our experience in this subject in a group of 136 patients (adolescents and adults) treated in the years 1996 to 2016. The study population was divided into two groups -108 patients with native CoA and 28 patients with ReCoA. There were no differences in the immediate and long-term outcomes between the groups. The conclusion of this study was that stenting in CoA and ReCoA is an effective and safe procedure with good late outcomes [1] . We also stated that the implantation of new large cobalt-chromium stents provides a good therapeutic option in such cases [2] Together with a group from Gdansk led by Dr. M. Chojnicki, we have recently reported on the application of ADOIIAS for closure of PDAs < 2.5 mm in diameter in older patients (also adults) [4] . The effectiveness, high closure rate, and lack of complications support the priority of ADOIIAS application instead of coils in the percutaneous closure of PDA.
Percutaneous pulmonary valve implantation (PPVI).
This relatively new technique is particularly useful in the case of significant pulmonary insufficiency and/or stenosis, for example after surgical corrections of tetralogy of Fallot. In our study (performed in cooperation with the Polish Mother's Memorial Hospital in Lodz) a group of 46 patients underwent PPVI. All implantation procedures were successful -44 Melody and two Edwards systems were used. The study concluded that PPVI is a safe procedure with encouraging results, and it enables deferment of surgical reintervention in the majority of patients with right ventricular outflow tract dysfunction [5] . 5. Miscellaneous papers. This point concerns several other important topics such as our positive experience in the percutaneous closure of patent foramen ovale in a case of cryptogenic stroke in children [6] or paravalvular aortic leak in a child [7] , and a novel technique of percutaneous downsizing of a Blalock-Taussig shunt by multiple stent-in-graft implantations [8] .
